{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:07:43Z","timestamp":1789373263362,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Breast cancer is one of the main causes of cancer death in women globally.\nIdentifying new predictive markers and therapeutic targets is important for improving patient\noutcomes. Zinc finger-containing U-rich RNA-binding protein 1 (ZUP1) is an RNA-binding\nprotein containing a zinc finger structure that has not been systematically analyzed in breast cancer\nresearch.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study used data from 1,231 samples from the Cancer Genome Atlas\n(TCGA) database. The ZUP1 expression in tumor tissues and normal tissues was compared. Its\npredictive value was assessed using survival analysis and regression models. Its biological role\nwas explored through gene functional analysis. The immune cell analysis method was used to\nstudy the tumor immune environment, and the drug susceptibility database was used to predict\ndrug responses. Predictive models were also built and validated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>ZUP1 expression was significantly higher in breast cancer tissues than in normal tissues.\nHigh expression of ZUP1 is related to advanced tumor stage and is an independent indicator\nof poor survival prognosis in univariate and multivariate analyses. Functional enrichment revealed\nthat ZUP1 is closely linked to cell cycle progression, DNA replication, and the Fanconi\nanemia (FA) pathway. Immune infiltration analysis demonstrated a significant negative link between\nZUP1 levels and the abundance of resting mast cells and activated NK cells. Furthermore,\nhigh ZUP1 expression was associated with increased sensitivity to several targeted therapies, including\nNutlin-3a and PD-0325901. A clinically applicable nomogram combining ZUP1 expression\nwith key clinical factors (age, stage, T, N, M) was developed to predict 3- and 5-year OS\nwith good calibration and discrimination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Our study identifies ZUP1 as a potential oncogenic factor and a robust independent\nprognostic biomarker in breast cancer. Its involvement in critical cellular processes and modulation\nof the tumor immune microenvironment highlights its potential as a novel therapeutic target.\nFunctional experiments, including immunohistochemical staining and CCK8 proliferation assays,\nfurther supported the oncogenic role of ZUP1. The established nomogram provides a valuable\ntool for personalized risk assessment and clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings suggest that ZUP1 is a novel multifaceted biomarker with significant\nimplications for personalized treatment strategies in breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113862073486848260808184821","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:03:43Z","timestamp":1789124623000},"source":"Crossref","is-referenced-by-count":0,"title":["ZUP1 as a Novel Potential Oncogenic Driver and Prognostic Biomarker in Breast Cancer"],"prefix":"10.2174","volume":"29","author":[{"given":"Weimiao","family":"Li","sequence":"first","affiliation":[{"name":"The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyou","family":"Shan","sequence":"additional","affiliation":[{"name":"The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqun","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7548-5028","authenticated-orcid":true,"given":"Guoxu","family":"Zheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Immunology, Fourth Military Medical University, Xi\u2019an, 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073486848260808184821","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258106\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113862073486848260808184821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:39:49Z","timestamp":1789371589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258106\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113862073486848260808184821","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}